Kodiak Sciences (KOD) Treasury Shares (2016 - 2025)
Kodiak Sciences (KOD) reported Treasury Shares of $120820.0 for Q4 2025, little changed on a YoY basis from $120820.0 in Q4 2024, and down 12.73% quarter-over-quarter from $138451.0 in Q3 2025.
Kodiak Sciences (KOD) Treasury Shares (2016 - 2025) Analysis & Trends
Kodiak Sciences has reported Treasury Shares for 10 years, with the latest figure at $120820.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $120820.0; the trailing twelve-month figure through Dec 2025 stood at $120820.0 (changed 0.0% YoY), and the FY2025 full-year result was $120820.0, changed 0.0% from the prior year.
- Treasury Shares for Q4 2025 stood at $120820.0, down from $138451.0 in the prior quarter.
- The five-year high for Treasury Shares was $412287.0 in Q3 2021, with the low at $117892.0 in Q2 2025.
- Historically, Treasury Shares has averaged $227141.7 across 5 years, with a median of $199622.0 in 2023.
- Annual changes were most pronounced in 2021 — Treasury Shares jumped 138.8% — and 2024, when it sank 46.0%.
- Kodiak Sciences' Treasury Shares stood at $363930.0 in 2021, then decreased by 22.92% to $280522.0 in 2022, then slumped by 41.25% to $164817.0 in 2023, then declined by 26.69% to $120820.0 in 2024, then changed by 0.0% to $120820.0 in 2025.
- The last three Treasury Shares figures came in at $120820.0 (Q4 2025), $138451.0 (Q3 2025), and $117892.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 120,820.00 |
| Dec 31, 2025 | 120,820.00 |
| Sep 30, 2025 | 138,451.00 |
| Sep 30, 2025 | 138,451.00 |
| Jun 30, 2025 | 117,892.00 |
| Jun 30, 2025 | 117,892.00 |
| Mar 31, 2025 | 133,253.00 |
| Mar 31, 2025 | 133,253.00 |
| Dec 31, 2024 | 120,820.00 |
| Dec 31, 2024 | 120,820.00 |
| Sep 30, 2024 | 122,349.00 |
| Sep 30, 2024 | 122,349.00 |
| Jun 30, 2024 | 127,521.00 |
| Jun 30, 2024 | 127,521.00 |
| Mar 31, 2024 | 151,716.00 |
| Mar 31, 2024 | 151,716.00 |
| Dec 31, 2023 | 164,817.00 |
| Dec 31, 2023 | 164,817.00 |
| Sep 30, 2023 | 186,267.00 |
| Sep 30, 2023 | 186,267.00 |